Skip to main content
Medigene AG logo

Medigene AG — Investor Relations & Filings

Ticker · MDG1 ISIN · DE000A40ESG2 LEI · 391200I33JD2DKZGDX06 F Professional, scientific and technical activities
Open in API
Filings indexed 114 across all filing types
Latest filing 2012-10-15 Report Publication Anno…
Country DE Germany
Listing F MDG1

About Medigene AG

https://medigene.com/

Medigene AG is a biotechnology company that develops T-cell receptor (TCR)-guided immunotherapies for the treatment of cancer. The company utilizes its proprietary End-to-End platform to discover and develop optimized 3S (sensitive, specific, safe) TCRs. These TCRs are designed for application across various therapeutic modalities, including TCR-T cell therapies, TCR-T cell engagers, and TCR-natural killer cell therapies, targeting different forms of cancer. A key clinical program is MDG1015, a third-generation TCR-T therapy targeting the NY-ESO-1/LAGE-1a antigen, which is enhanced with a PD1-41BB costimulatory switch protein. As of August 2025, the company is undergoing insolvency proceedings.

Recent filings

Filing Released Lang Actions
Hinweis auf Quartalsfinanzbericht vom 01.01.2012 bis zum 30.09.2012
Report Publication Announcement Classification · 100% confidence The document is a short notification (under 1,000 characters) that informs the public about the upcoming availability of a quarterly financial report. It explicitly states 'Hinweis auf Quartalsfinanzbericht' (Notice of Quarterly Financial Report) and provides a URL where the report can be accessed. Following the 'Menu vs Meal' rule, this is an announcement of a report rather than the report itself, making it a Report Publication Announcement (RPA).
2012-10-15 German
Datum:15.10.2012
Report Publication Announcement Classification · 100% confidence The document is a short notification (936 characters) informing the public that a quarterly financial report for the period 01.01.2012 to 30.09.2012 is available on the company's website. It does not contain the financial report itself, but rather serves as an announcement of its publication. Following the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA).
2012-10-15 German
Datum:13.08.2012
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Quartalsfinanzbericht zum 30. Juni 2012' (Quarterly Financial Report as of June 30, 2012) for Medigene AG. It contains detailed financial statements, including a 'Gekürzte Konzern-Gewinn- und Verlustrechnung' (Condensed Consolidated Income Statement), analysis of revenue, operating costs, and business developments for the first half of 2012. Since it provides substantive financial data and analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H1 2012
2012-08-13 German
Datum:13.07.2012
Report Publication Announcement Classification · 100% confidence The document is a short notification (946 characters) informing shareholders that a quarterly financial report has been published and providing a link to access it on the company's website. Per the 'Menu vs Meal' rule, since this is an announcement of a report rather than the report itself, it is classified as a Report Publication Announcement (RPA).
2012-07-13 German
Datum:23.05.2012
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Quartalsfinanzbericht zum 31. März 2012' (Quarterly Financial Report for March 31, 2012) for Medigene AG. It contains detailed financial statements, including a consolidated income statement, analysis of revenue, R&D costs, and EBITDA, covering the first quarter of 2012. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2012
2012-05-23 German
Datum:10.05.2012
Management Reports Classification · 100% confidence The document is a 'Konzern-Lagebericht' (Group Management Report) for MediGene AG for the fiscal year 2011. It contains detailed sections on business overview, product portfolio, financial performance, risk management, and corporate governance. While it is part of the annual reporting package, the text specifically identifies itself as the 'Konzern-Lagebericht' (Management Report), which is a core component of the Annual Report (10-K equivalent in this context). Given the length and comprehensive nature of the content, it is classified as an Annual Report.
2012-05-10 German

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.